Growing Onglyza Cases May Prove to be a Burden for the Manufacturers

Introduction

A product liability lawsuit was filed in the U.S. District Court for the Southern District of Ohio by the widow of an Ohio man, who claims the use of Onglyza was the reason for the congestive heart failure suffered by her husband before his death.

Onglyza cases are centralized as a part of MDL No. 2809, which is witnessing a steady rise in the number of lawsuits as expected since its establishment in February, in the U.S. District Court for the Eastern District of Kentucky under U.S. District Judge Karen K. Caldwell.

Bristol-Myers Squibb and AstraZeneca are the defendants named in the Onglyza litigation over its alleged link to congestive heart failure and other side effects. Plaintiffs hold them responsible for not providing adequate cardiovascular injury warnings despite having the knowledge.

Comments

Purdue, Sacklers Agree to New $7.4B Opioid Settlement

Categories: Opioids

All 50 U.S. states, along with the District of Columbia and U.S. territories, have agreed to a $7.4 billion settlement with Purdue Pharma, the manufacturer of OxyContin.

This deal addresses allegations that the company’s aggressive and…

Oregon to Get $66M in Sackler Opioid Settlement

Categories: Opioids

Oregon will gain $66 million as part of a nationwide settlement with the Sackler family and Purdue Pharma, the makers of OxyContin. The funds will be used to expand and…

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

Growing Onglyza Cases May Prove to be a Burden for the Manufacturers